Rhodiola Rosea

Rhodiola's neurotransmitter effects are particularly significant in the prefrontal cortex and hippocampus. Rhodiola can produce improvements in cognition, mood, and performance within hours or days of starting use. Rhodiola acts relatively quickly compared to ashwagandha. Rhodiola dosage in most studies ranges from 100 to 600 mg daily. Meta-analysis evidence for rhodiola is smaller in volume and comes from studies with mixed data quality compared to ashwagandha research. Rhodiola's primary mechanism is inhibiting monoamine oxidase (MAO), an enzyme that breaks down key neurotransmitters. Rhodiola stimulates the central nervous system rather than calming it. Rhodiola uses a bottom-up mechanism, acutely raising neurotransmitter levels at the neurochemical level to decrease fatigue. Rhodiola inhibits monoamine oxidase (MAO), raising available dopamine, serotonin, norepinephrine, and beta-endorphins in the brain. Rhodiola stimulates glucose uptake in muscles, reducing mental fatigue under stress. Rhodiola's primary active compounds include tyrosol, salidroside, and rosavin. Rhodiola is more appropriate for people with depressive symptoms or chronic fatigue who need an acute energy lift.